None listed
Conditions
Brief summary
The purpose of this study is to see if physical activity in hospitalised patients can be increased using a commercially available ‘smart watch’ device that monitors activity levels. Who is it for? You may be eligible for this study if you are aged 18 or over and have been admitted to St Vincent’s Hospital in Sydney under the care of an oncology or haematology team, with a cancer diagnosis. Study details Participants in this study will be randomised by chance (like flipping a coin) into two groups. Participants in both groups will wear a commercially available smart watch (Samsung Galaxy S3) for the duration of their inpatient stay. One group will have daily goal-setting session with a physiotherapist, and be encouraged to use the smart watch to monitor their activity levels and achieve the set goals. The other group will have standard physiotherapist visits, and will wear the watch and have activity monitored, but will be unable to use the watch as it will be locked. All participants will also wear a step counter on the thigh for certain periods of the trial, and will complete questionnaires at the end of their inpatient stay. Participants in the active group will also be interviewed to obtain feedback on the intervention. It is hoped this research will provide some preliminary evidence about the feasibility of using smart watches to promote physical activity in hospitals.
Interventions
Participants in the intervention group will receive daily physiotherapy review for goal setting, and education on the use of a smart watch (Samsung Galaxy S3) to monitor steps taken per day and 'active minutes' per day. Participants in the intervention group will be encouraged to check their 'smart watch' through the day, to track number of steps and 'active minutes' and assist with goal attainment. By contrast, participants in the control group will have a 'locked' watch face and be unable to v
Participants in the intervention group will receive daily physiotherapy review for goal setting, and education on the use of a smart watch (Samsung Galaxy S3) to monitor steps taken per day and 'active minutes' per day. Participants in the intervention group will be encouraged to check their 'smart watch' through the day, to track number of steps and 'active minutes' and assist with goal attainment. By contrast, participants in the control group will have a 'locked' watch face and be unable to view the watch face to track their activity levels. Participants will be also be provided with written educational materials promoting physical activity, and an exercise logbook to record type and duration of exercise per day. The educational material has been produced specifically for this study, and includes images and information obtained from the Cancer Council of Australia's 'Exercise for People Living with Cancer' information booklet, and the Clinical Oncology Society of Australia (COSA) Position Statement on Exercise in Cancer Care. An ActivPAL device will be worn by participants in both the intervention and control arms for 72 hours at the beginning of each week. The purpose of the ActivPAL is to provide an additional way of recording number of steps and activity levels, and assessing the accuracy of the smart watch data. The intervention will be delivered daily by a physiotherapist for the duration of the inpatient admission, for up to 20 days. The intervention will take place on the oncology and haematology wards of St Vincent's Hospital. Goals are initially set based upon the result of the baseline number of steps and 'active minutes' obtained from the smart watch, measured over 24 hours. Participants will initially be given a goal of increasing number of steps by 20% over the following 24 hours, and to gradually increase 'active minutes' towards the COSA guidelines of 20-30 minutes per day. The daily goal will continue to consist of a 20% increase in steps, so long as this goal is achieved. If the 20% target is not achieved, the target increase will be reduced to 10%, and if this is not achieved, it will be reduced to 5%. Minimum duration of participation is 5 days, and maximum 20 days.
Sponsors
St Vincent’s Clinic Foundation
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
· Adults aged 18 years and over · Admitted to St Vincent’s Public Hospital, Sydney, under the care of an oncology or haematology team, with a cancer diagnosis (solid organ or haematological malignancy) · Patient is located on Ward 8S (oncology) or 9S (haematology) · Able to walk without assistance, as assessed formally by the ward physiotherapist · Expected inpatient length of stay >5 days · Able to provide written informed consent, and to participate and comply with study procedures
Exclusion criteria
· Medically unfit to participate in an exercise programme, as deemed by the treating medical team · Non-independent with transfers and/or mobility (i.e. requires assistance), as deemed by the treating ward physiotherapist · Non-English speaking patients. Because in-depth, daily communication between participants and physiotherapist is an essential component of this study, and due to the limited budget of this pilot study, using a translator will be not be feasible. · Individuals who have already participated in the trial (e.g. during an earlier admission to hospital) · Bone marrow transplant recipients, due to high medical acuity and likely inability to consistently participate in the trial
Outcome results
None listed